Opportunity, I do not think a new CEO would get the stock noticed an better than what Dr. Moro is currently doing. Promoting OTC.BB stocks is very difficult. No analysts want to hang out their rep for the company and BioCurex is limited in funds to do much else. However, I would certainly get rid of Wittenberg and get a new CFO.
News 
Market Data 
Discover 
AI
